rs146530638
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 1P and 0B. PP3
The NM_002691.4(POLD1):c.2066G>A(p.Arg689Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000347 in 1,613,270 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R689W) has been classified as Uncertain significance.
Frequency
Consequence
NM_002691.4 missense
Scores
Clinical Significance
Conservation
Publications
- POLD1-related polyposis and colorectal cancer syndromeInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- colorectal cancer, susceptibility to, 10Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp
- mandibular hypoplasia-deafness-progeroid syndromeInheritance: AD, AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Genomics England PanelApp, Ambry Genetics, Orphanet, G2P
- Polymerase proofreading-related adenomatous polyposisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- immunodeficiency 120Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
- non-severe combined immunodeficiency due to polymerase delta deficiencyInheritance: AR Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| POLD1 | NM_002691.4 | c.2066G>A | p.Arg689Gln | missense_variant | Exon 17 of 27 | ENST00000440232.7 | NP_002682.2 | 
Ensembl
Frequencies
GnomAD3 genomes  0.00000657  AC: 1AN: 152254Hom.:  0  Cov.: 32 show subpopulations 
GnomAD2 exomes  AF:  0.0000400  AC: 10AN: 250114 AF XY:  0.0000443   show subpopulations 
GnomAD4 exome  AF:  0.0000376  AC: 55AN: 1461016Hom.:  0  Cov.: 32 AF XY:  0.0000371  AC XY: 27AN XY: 726834 show subpopulations 
Age Distribution
GnomAD4 genome  0.00000657  AC: 1AN: 152254Hom.:  0  Cov.: 32 AF XY:  0.00  AC XY: 0AN XY: 74374 show subpopulations 
ClinVar
Submissions by phenotype
not provided    Uncertain:1 
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Observed in individuals with colorectal cancer or hypertriglyceridemia (PMID: 29120461, 32041611); This variant is associated with the following publications: (PMID: 32041611, 34326862, 29120461) -
Colorectal cancer, susceptibility to, 10    Uncertain:1 
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 689 of the POLD1 protein (p.Arg689Gln). This variant is present in population databases (rs146530638, gnomAD 0.008%). This variant has not been reported in the literature in individuals affected with POLD1-related conditions. ClinVar contains an entry for this variant (Variation ID: 408026). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt POLD1 protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Hereditary cancer-predisposing syndrome    Uncertain:1 
The p.R689Q variant (also known as c.2066G>A), located in coding exon 16 of the POLD1 gene, results from a G to A substitution at nucleotide position 2066. The arginine at codon 689 is replaced by glutamine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this variant remains unclear. -
Colorectal cancer, susceptibility to, 10;C3715192:Mandibular hypoplasia-deafness-progeroid syndrome;C5935622:Immunodeficiency 120    Uncertain:1 
- -
Colorectal cancer, susceptibility to, 10;C3715192:Mandibular hypoplasia-deafness-progeroid syndrome    Other:1 
Variant interpreted as Uncertain significance and reported on 05-20-2022 by Invitae. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at